The cancer-associated BRCT domain defects in BRCA1 that suppressed the phosphorylated RNA polymerase II (RNAP II) carboxy terminal domain (P-CTD) cleavage and lethality in yeast also suppressed the physical interaction of BRCA1 with human SPT5 in breast epithelial cells. Here, BRCA1 is linked to cancer.